Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_602e84c727e976e9f361ebbb6b5781fd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
filingDate |
1999-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e7b0bfb139b31a1c18ff85e803306d |
publicationDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-PA01003105-A |
titleOfInvention |
INFECTION TREATMENT FOR THE VIRUS OF HEPATITIS B WITH ALPHA TIMOSINE IN COMBINATION WITH LAMIVUDINE OR IN COMBINATION WITH LAMIVUDINE AND FAMCICLOVIR. |
abstract |
Treatment of hepatitis B virus (HBV) infection in a patient by administering to the patient a drug regimen that includes an antiviral-effective amount of thymosin alpha 1 (Ta1), an antiviral-effective amount of lamivudine, and in a manner optional an antiviral-effective amount of famciclovir. |
priorityDate |
1998-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |